Satellos Bioscience Inc.(NasdaqGM: MSLE) added to NASDAQ Composite Index
Satellos Bioscience Inc.(NasdaqGM: MSLE) added to NASDAQ Compos…
1 month ago
marketscreener.com
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Du…
1 week ago
thespec.com
Une publication scientifique valide l'approche thérapeutique de Satellos Bioscience contre la dystrophie musculaire de Duchenne
Une publication scientifique valide l'approche thérapeutique de Satell…
4 months ago
zonebourse.com
Satellos Announces New Data Further Demonstrating Safety, Tolerability, and Functional Impact of SAT-3247 in First-in-Human Trial of Adults with Duchenne Muscular Dystrophy
Satellos Announces New Data Further Demonstrating Safety, Tol…
5 months ago
financialpost.com
Webinar: Exploring Muscle Regeneration - A New Approach with Satellos
56:19
Webinar: Exploring Muscle Regeneration - A New Approach w…
2.1K viewsNov 5, 2024
YouTubeParent Project Muscular Dystrophy
Satellos Bioscience annonce une consolidation de ses actions en vue d'une inscription envisagée au Nasdaq
Satellos Bioscience annonce une consolidation de ses actions en v…
1 month ago
zonebourse.com
Satellos Bioscience | Turning real biology into real progress. That’s what today looks like at Satellos. → Explore our science: satellos.com/science... | Instagram
0:05
Satellos Bioscience | Turning real biology into real progress. That’s …
1.3K views1 month ago
Instagramsatellosbioscience
1:23:15
Satellos Bioscience (MSCL) Encouraging Phase 1b Trial Data: …
3.8K views9 months ago
YouTubeRadius Research
2:18
Satellos: SAT-3247 Mechanism of Action
11.6K views7 months ago
VimeoSatellos Bioscience
Satellos announces first participant dosed in phase 2 pediatric study o…
1 month ago
marketscreener.com
1:01:44
Satellos Bioscience (MSCL) CEO Frank Gleeson, CMO Dr. Wildon F…
1.5K views4 months ago
YouTubeRadius Research
Satellos : le SAT-3247 confirme sa sécurité et sa tolérance lors d'une …
5 months ago
zonebourse.com
15:42
CureDuchenne FUTURES 2025 - Satellos Bioscience
14 views9 months ago
VimeoSatellos Bioscience
2:18
Satellos DMD therapy - 3D animation
648 views7 months ago
YouTubeLife Science Animation
Satellos Closes US$57.2 Million Public Offering in Canada and the …
1 month ago
marketscreener.com
SAT-3247 and Restoring Muscle Regeneration in Duchenne Muscul…
1 year ago
neurologylive.com
42:01
Pioneering Duchenne Muscular Dystrophy Treatment with Satello…
563 viewsApr 17, 2024
YouTubeDestroy Duchenne
Ottawa biotech startup gets US$1M boost in quest to find treatment fo…
Jan 23, 2021
obj.ca
48:03
Satellos Bioscience (MSCL) CEO Frank Gleeson: & CTO Phil Lambe…
994 viewsOct 23, 2022
YouTubeRadius Research
1:02:56
Satellos Bioscience (MSCL) CEO Frank Gleeson: Phase 1 & 2 Milest…
5.8K viewsOct 6, 2024
YouTubeRadius Research
51:31
EP 190: Targeting regeneration to tackle Duchenne Muscular Dystro…
420 views9 months ago
YouTubeSano Genetics
1:06:58
Satellos (MSCL) - Presentation, Deep Dive and Q&A with CEO Fra…
756 viewsFeb 13, 2022
YouTubeRadius Research
14:51
New Treatment Option (SAT-3247) for Duchenne Muscular Dystroph…
872 views4 months ago
YouTubeCheckRare
8:13
Satellos BioScience files patents as company looks to help in the treat…
1.6K viewsJun 23, 2022
YouTubeProactive Investors
51:36
Satellos 宣布 SAT-3247 治疗成人杜氏肌营养不良症的 28 天 1b 期开放 …
48 views9 months ago
bilibiliDMD海外信息
2:05:43
Afternoon Drug Development & Clinical Trial Presentations
273 views7 months ago
YouTubeFSHD Society
News for MSCLF
3 months ago
zacks.com
Newly Formed Clinical Advisory Board United in Potential of SAT-3…
Jun 13, 2024
neurologylive.com
59:37
Shaping the Future: Leadership and Vision at Satellos
306 viewsSep 3, 2024
YouTubeDestroy Duchenne
0:49
Satillos Family on Reels
76.7K viewsApr 10, 2022
FacebookSatillos Family
See more videos
Static thumbnail place holder